Literature DB >> 34453230

Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample.

Mavi Rivera1, A Villafranca2, P Khamooshi3, V Reyes3, J Sanchez3, A Manadan4.   

Abstract

OBJECTIVE: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a heterogeneous group of conditions resulting in frequent hospitalizations and high in-hospital mortality (IHM). Our study aimed to use the National Inpatient Sample (NIS) to determine and categorize the main reasons for hospital admission and IHM in patients with AAV.
METHODS: We performed a retrospective study of adult AAV hospitalizations in 2016, 2017, and 2018 in acute care hospitals across the USA conducted using the NIS database. We classified the main reasons for hospital admission and IHM into 19 different categories using the principal International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) diagnosis.
RESULTS: A total of 41,155 hospitalizations had either a principal or secondary ICD-10 code for AAV (GPA or MPA). Rheumatologic and respiratory diagnoses were the most common reasons for hospitalization, while infectious and respiratory diagnoses were the most common reasons for IHM. Sepsis, unspecified organism A41.9, was the most common specific principal diagnosis for hospitalized and deceased AAV patients.
CONCLUSIONS: Our results show that the leading reasons for hospitalization and mortality for AAV patients were rheumatologic, respiratory, and infectious diagnoses. This data suggests that careful monitoring and management of infectious and pulmonary complications in AAV may improve hospital outcomes. Key points • AAV is a heterogeneous group of conditions resulting in frequent hospitalizations and high IHM. In our study, AAV hospitalizations ended in IHM 4.5% of the time, substantially greater than non-ANCA patients. • The leading reasons for hospital admission for AAV patients were rheumatologic and respiratory diagnoses, but the main reason for IHM were infectious and respiratory diagnoses. • Sepsis was the most common principal diagnosis for hospitalized and deceased AAV patients. • Our results highlight the importance of close monitoring and timely management of infectious and respiratory complications to improve hospitalization outcomes.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Granulomatosis with polyangiitis; Hospitalizations; Microscopic polyangiitis; Mortality; The manuscript has not been published elsewhere

Mesh:

Substances:

Year:  2021        PMID: 34453230     DOI: 10.1007/s10067-021-05880-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Respiratory failure in ANCA-associated vasculitis.

Authors:  J C ter Maaten; C F Franssen; R O Gans; R J van Schijndel; S J Hoorntje
Journal:  Chest       Date:  1996-08       Impact factor: 9.410

Review 2.  Vasculitis and infection: effects of immunosuppressive therapy.

Authors:  H M Lode; M Schmidt-Ioanas
Journal:  Clin Nephrol       Date:  2005-12       Impact factor: 0.975

3.  Thirty-Day Hospital Readmissions for Granulomatosis With Polyangiitis in the United States: A Nationwide Analysis.

Authors:  Yiming Luo; Changchuan Jiang; Ana Belen Arevalo Molina; Shane Murray; Gustavo Contreras Anez; Maria Salgado; Jiehui Xu
Journal:  J Clin Rheumatol       Date:  2020-08       Impact factor: 3.517

Review 4.  Wegener's Granulomatosis vasculitis and granuloma.

Authors:  Anna M Schilder
Journal:  Autoimmun Rev       Date:  2010-02-13       Impact factor: 9.754

5.  Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis.

Authors:  Fernando Holguin; Bassel Ramadan; Anthony A Gal; Jesse Roman
Journal:  Am J Med Sci       Date:  2008-10       Impact factor: 2.378

6.  Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit.

Authors:  Doubravka Frausova; Martina Brejnikova; Zdenka Hruskova; Zuzana Rihova; Vladimir Tesar
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

7.  Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients.

Authors:  Qing-Ying Lai; Tian-Tian Ma; Zhi-Ying Li; Dong-Yuan Chang; Ming-Hui Zhao; Min Chen
Journal:  J Rheumatol       Date:  2014-08-01       Impact factor: 4.666

Review 8.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

Review 9.  Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease.

Authors:  Jose A Gómez-Puerta; José Hernández-Rodríguez; Alfonso López-Soto; Xavier Bosch
Journal:  Chest       Date:  2009-10       Impact factor: 9.410

Review 10.  The antineutrophil cytoplasmic antibody-associated vasculitides.

Authors:  Philip Seo; John H Stone
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.